The FDA is a separate event initiated by the FDA. The selection process to be part of the challenge is decided by the FDA. If the FDA selects BIEL, they will win it, as many others would have applied and rejected. Being part of the FDA innovation challenge is a HUGE WIN for Biel.
We all know that the FDA innovation challenge has nothing to do with BIEL being cleared for Actipatch and RecoveryRx. Those are two separate tracks, but based on the CEO radio interview, he elected to wait for the challenge and have RecoveryRx part of it to facilitate and expedite RecoveryRX clearance with the help and exposure of the FDA through the challenge. I invite you to read the radio interview before the last one on record.
Every time you enter a context and you are selected and others rejected, you win, and this will be a HUGE WIN for BIEL, if selected by the FDA in November.
News 
Market Data 
Discover 
AI
